Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Event Logistics

- PMLiVE

Eli Lilly’s oral weight-loss candidate orforglipron shows promise in late-stage trial

The company is planning to submit the candidate for regulatory review by the end of the year

- PMLiVE

Jason Reese appointed as VML Health’s global chief transformation officer

Reese to spearhead business transformation and digital innovation

- PMLiVE

Medscape Education: Celebrating the Power, Purpose, and Future of Women in Medicine

Medscape Education is proud to return to the Power of Women in Medicine Summit™, reaffirming its commitment to uplifting, empowering, and amplifying women across healthcare. As a sponsor, Medscape brings...

Medscape Education

- PMLiVE

UK government publishes 10-Year Health Plan for England to ‘reinvent’ NHS

The plan’s three overarching themes are hospital to community, analogue to digital and sickness to prevention

- PMLiVE

Novartis’ ianalumab shows promise in phase 3 Sjögren’s syndrome studies

The systemic autoimmune disease affects approximately 0.6% of the UK’s adult population

- PMLiVE

Almirall and Absci expand AI dermatological drug discovery partnership

The alliance has already led to the delivery of functional antibody leads against a difficult-to-drug target

Is AI the answer? Translating complex medical information into public understanding

By Rebecca Helson and Ben Clarke

Amiculum

- PMLiVE

NEW Pharma-exclusive Webinar: From Fragmented to Flawless, A Blueprint for Unified Omnichannel in Pharma

Tired of a fragmented omnichannel strategy that falls short of its promise? Join our free webinar on Oct 28 & 29 to get the blueprint for a truly unified and...

Impetus Digital

- PMLiVE

Medscape Cardiology: Leading the Future of Heart Failure Education at HFSA 2025

Medscape Cardiology | theheart.org is proud to be at the forefront of the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM), September 26–29, 2025, in Minneapolis, MN! With...

Medscape Education

- PMLiVE

Boehringer’s Hernexeos granted FDA accelerated approval for lung cancer patients

Approximately 226,650 lung cancer cases are expected to be diagnosed in the US this year

- PMLiVE

FDA approves Celltrion’s Actemra biosimilar Avtozma for cytokine release syndrome

Avtozma IV now fully aligns with all indications covered by Actemra IV in the US

- PMLiVE

Why life cycle management is pharma’s most underrated capability

How early decisions, strategic agility and cross-functional intent unlock lasting brand value

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links